Clinical impact of the worldwide shortage of verteporfin (Visudyne®) on ophthalmic care-Reference-Cited by-全球学者库

Clinical impact of the worldwide shortage of verteporfin (Visudyne®) on ophthalmic care

Published:2022-04-06 Issue:7 Volume:100 Page:
ISSN:1755-375X
Container-title:Acta Ophthalmologica
language:en
Short-container-title:Acta Ophthalmologica

Author:

Sirks Marc J.¹^ORCID,van Dijk Elon H.C.²^ORCID,Rosenberg Noa³⁴^ORCID,Hollak Carla E.M.³⁴⁵^ORCID,Aslanis Stamatios⁶^ORCID,Cheung Chui Ming Gemmy⁷⁸^ORCID,Chowers Itay⁹¹⁰,Eandi Chiara M.¹¹¹²^ORCID,Freund K. Bailey¹³¹⁴^ORCID,Holz Frank G.¹⁵,Kaiser Peter K.¹⁶^ORCID,Lotery Andrew J.¹⁷^ORCID,Ohno‐Matsui Kyoko¹⁸^ORCID,Querques Giuseppe¹⁹^ORCID,Subhi Yousif²⁰²¹^ORCID,Tadayoni Ramin²²²³²⁴^ORCID,Wykoff Charles C.²⁵²⁶^ORCID,Zur Dinah²⁷²⁸^ORCID,Diederen Roselie M.H.¹^ORCID,Boon Camiel J.F.¹²^ORCID,Schlingemann Reinier O.¹¹¹

Affiliation:

1. Department of Ophthalmology Amsterdam University Medical Centres University of Amsterdam Amsterdam The Netherlands

2. Department of Ophthalmology Leiden University Medical Centre Leiden The Netherlands

3. Medicine for Society Platform at Amsterdam University Medical Centres ‐ University of Amsterdam Amsterdam The Netherlands

4. Department of Endocrinology and Metabolism Amsterdam UMC ‐ University of Amsterdam Amsterdam The Netherlands

5. Sphinx Amsterdam Lysosome Center Amsterdam The Netherlands

6. St. Erik Eye Hospital Stockholm Sweden

7. Singapore National Eye Center Singapore Singapore

8. Singapore Eye Research Institute Singapore Singapore

9. Department of Ophthalmology Hadassah Medical Center Jerusalem Israel

10. Faculty of Medicine Hebrew University of Jerusalem Jerusalem Israel

11. Department of Ophthalmology University of Lausanne, Jules Gonin Eye Hospital, Fondation Asile Des Aveugles Lausanne Switzerland

12. Department of Surgical Sciences University of Turin Turin Italy

13. Vitreous Retina Macula Consultants of New York New York New York USA

14. Department of Ophthalmology New York University Grossman School of Medicine New York New York USA

15. Department of Ophthalmology University of Bonn Bonn Germany

16. Cole Eye Institute Cleveland Ohio USA

17. Faculty of Medicine University of Southampton Southampton UK

18. Tokyo Medical and Dental University Tokyo Japan

19. IRCCS San Raffaele Scientific Institute University Vita Salute San Raffaele Milan Italy

20. Department of Ophthalmology Rigshospitalet Glostrup Denmark

21. Department of Clinical Research University of Southern Denmark Odense Denmark

22. University of Paris Paris France

23. Hôpital Lariboisière, AP‐HP Paris France

24. Hôpital Fondation Adolphe de Rothschild Paris France

25. Retina Consultants of Texas, Retina Consultants of America Houston Texas USA

26. Blanton Eye Institute Houston Methodist Hospital Houston Texas USA

27. Ophthalmology Division Tel Aviv Medical Center Tel Aviv Israel

28. Sackler Faculty of Medicine Tel Aviv University Tel Aviv Israel

Publisher

Wiley

Subject

Ophthalmology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/aos.15148

Reference68 articles.

1. Indocyanine green and laser light for the treatment of AIDS-associated cutaneous Kaposi's sarcoma

2. Future of oncologic photodynamic therapy

3. Circumscribed Choroidal Hemangiomas

4. Porphyrins, porphyrias, cancer and photodynamic therapy — a model for carcinogenesis

5. Generic Competition for Drugs Treating Rare Diseases

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BASELINE SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHIC RETINAL LAYER FEATURES IDENTIFIED BY ARTIFICIAL INTELLIGENCE PREDICT THE COURSE OF CENTRAL SEROUS CHORIORETINOPATHY;Retina;2024-02

2. A randomized non-inferiority trial of 577nm subthreshold micropulse laser versus half-dose photodynamic therapy for acute central serous chorioretinopathy;Photodiagnosis and Photodynamic Therapy;2024-02

3. Central serous chorioretinopathy: An evidence-based treatment guideline;Progress in Retinal and Eye Research;2024-02

4. A comparison between the effects of two liposome-encapsulated bevacizumab formulations on ocular neovascularization inhibition;Colloids and Surfaces B: Biointerfaces;2024-02

5. Comparative efficacy of brolucizumab, half-dose photodynamic therapy, and aflibercept in managing chronic central serous chorioretinopathy;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-01-15